Artigo de periodico

The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis (2019)

• Authors:
  • Ahmad, Akbar
  • Vieira, Juliana de Camargo
  • Mello, Aline Haas de
  • Lima, Thais Martins de
  • Ariga, Suely Kubo
  • Barbeiro, Denise Frediani
  • Barbeiro, Hermes Vieira
  • Szczesny, Bartosz
  • Toro, Gabor
  • Druzhyna, Nadiya
• USP affiliated authors: BARBEIRO, DENISE FREDIANI - FM ; SORIANO, Francisco Garcia - FM
• Unidade: FM
• DOI: 10.1016/j.phrs.2019.104263
• Subjects: TRANSFERASES; CAMUNDONGOS; CHOQUE SÉPTICO; ESTRESSE OXIDATIVO; LIGADURA; PUNÇÕES
• Agências de fomento:
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • Financiado pela SNSF
  • National Institutes of Health [R01GM107876]
• Language: Inglês
• Imprenta:
  • Publisher place: London
  • Date published: 2019
• Source:
  • Título: Pharmacological research
  • ISSN: 1043-6618
  • Volume/Número/Paginação/Ano: v. 145, article ID UNSP 104263, 29p, 2019


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo possui versão em acesso aberto em repositório (Green Open Access)

Versão do Documento:

Versão submetida (Pré-print)

Acessar versão aberta:

• URL de acesso aberto
• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  AHMAD, Akbar et al. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, v. 145, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2019.104263. Acesso em: 02 abr. 2026.

• APA

  Ahmad, A., Vieira, J. de C., Mello, A. H. de, Lima, T. M. de, Ariga, S. K., Barbeiro, D. F., et al. (2019). The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacological research, 145. doi:10.1016/j.phrs.2019.104263

• NLM

  Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2026 abr. 02 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263

• Vancouver

  Ahmad A, Vieira J de C, Mello AH de, Lima TM de, Ariga SK, Barbeiro DF, Barbeiro HV, Szczesny B, Toro G, Druzhyna N. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis [Internet]. Pharmacological research. 2019 ; 145[citado 2026 abr. 02 ] Available from: https://doi.org/10.1016/j.phrs.2019.104263

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity' for repurposing a clinically used oncological drug for the experimental therapy of sepsis
• Treg and NK cells related cytokines are associated with deep rectosigmoid endometriosis and clinical symptoms related to the disease
• Participação da célula B-1 na resposta inflamatória ao lipopolissacáride
• Correlations between food intake, lipid profile and inflammation in patients with metabolic syndrome
• Reposição volêmica e resposta inflamatória em ratos endotoxêmicos
• Crotoxin modulates inflammation and macrophages?: functions in a murine sepsis model
• Endothelial injury in COVID-19 and septic patients
• Gastrin-releasing peptide receptor antagonist effect on an animal model of sepsis
• Mechanical ventilation in healthy lungs and micromechanics: Increase in tissue elastance and resistance in the non dependant lung within 30 min
• Hypertonic saline solution reduces the inflammatory response in endotoxemic rats